World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 74 2055 1883 1005 909 249 19761
Medicine 74 19403 18209 9662 8912 253 19762

Edwin D. Charlebois publications per year

The chart shows the history of publications by Edwin D. Charlebois between 1993 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Edwin D. Charlebois published across 33 years, from 1993 to 2025, averaging 8.3 papers a year. Output peaked at 16 publications in 2004. 22 of the 274 publications appeared in the last two years.

No. of publications
5 10 15
Bar chart. Horizontal axis: year, 1993 to 2025. Vertical axis: number of publications, 0 to 16. Peak 16 publications in 2004. 1993: 5 publications 1994: 4 publications 1995: 1 publication 1996: 5 publications 1997: 2 publications 1998: 0 publications 1999: 1 publication 2000: 4 publications 2001: 5 publications 2002: 2 publications 2003: 3 publications 2004: 16 publications 2005: 6 publications 2006: 7 publications 2007: 12 publications 2008: 6 publications 2009: 5 publications 2010: 9 publications 2011: 9 publications 2012: 10 publications 2013: 14 publications 2014: 14 publications 2015: 10 publications 2016: 15 publications 2017: 13 publications 2018: 10 publications 2019: 12 publications 2020: 16 publications 2021: 11 publications 2022: 16 publications 2023: 9 publications 2024: 9 publications 2025: 13 publications
1993 2025

274 publications in total across all disciplines

View publications per year as a table
Edwin D. Charlebois: publications per year, 1993 to 2025
Year Publications
1993 5
1994 4
1995 1
1996 5
1997 2
1998 0
1999 1
2000 4
2001 5
2002 2
2003 3
2004 16
2005 6
2006 7
2007 12
2008 6
2009 5
2010 9
2011 9
2012 10
2013 14
2014 14
2015 10
2016 15
2017 13
2018 10
2019 12
2020 16
2021 11
2022 16
2023 9
2024 9
2025 13
Total 274
Download as CSV

Edwin D. Charlebois publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Edwin D. Charlebois sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 242–251 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 249 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160 249
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Edwin D. Charlebois D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Edwin D. Charlebois sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 74–75 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133 74
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Research.com Recognitions

  • 2002 - Hellman Fellow

Overview

Edwin D. Charlebois is affiliated with the University of California, San Francisco in the United States. Their scholarly contributions primarily fall within the field of Medicine, encompassing a total of 120 publications. Within this broad domain, they have a focused interest in subfields such as Infectious Diseases, General Health Professions, Epidemiology, Virology, and Sociology and Political Science.

The scientist's research work extensively covers topics related to HIV/AIDS and sexual health, including HIV/AIDS Research and Interventions, HIV, Drug Use, Sexual Risk, Adolescent Sexual and Reproductive Health, HIV Research and Treatment, Global Maternal and Child Health, Sex Work and Related Issues, and HIV/AIDS Impact and Responses.

Recent representative papers by Edwin D. Charlebois include:

  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections, 2023, New England Journal of Medicine
  • Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study, 2020, The Lancet HIV
  • Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study, 2020, AIDS and Behavior
  • Drought and intimate partner violence towards women in 19 countries in sub-Saharan Africa during 2011-2018: A population-based study, 2020, PLoS Medicine
  • HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda, 2021, PLoS Medicine

Edwin D. Charlebois frequently collaborates with other researchers, with notable co-authors including Moses R. Kamya, Diane V. Havlir, Jane Kabami, Elizabeth A. Bukusi, and Maya Petersen. These collaborations reflect a cohesive network in infectious disease and HIV research.

The scientist has published multiple studies in respected venues, with frequent publications in UNC Libraries, PLoS ONE, JAIDS Journal of Acquired Immune Deficiency Syndromes, AIDS and Behavior, and PLoS Medicine. This range indicates active engagement with diverse academic platforms specializing in infectious diseases and public health.

Edwin D. Charlebois received the Hellman Fellow award in 2002.

Best Publications

  • Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.

    David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Andrew R. Zolopa

  • Non-adherence to highly active antiretroviral therapy predicts progression to Aids

    David R. Bangsberg;Sharon Perry;Edwin D. Charlebois;Richard A. Clark

  • High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections

    Bradley W. Frazee;Jeremy Lynn;Edwin D. Charlebois;Larry Lambert

  • Decline in HIV infectivity following the introduction of highly active antiretroviral therapy.

    Travis C Porco;Jeffrey N Martin;Kimberly A Page-Shafer;Amber Cheng

  • Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections.

    Unknown

  • Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale.

    Thomas P. Giordano;David Guzman;Richard Clark;Edwin D. Charlebois

  • Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.

    Jessica H. Oyugi;Jayne Byakika-Tusiime;Edwin D. Charlebois;Cissy Kityo

  • High levels of adherence do not prevent accumulation of HIV drug resistance mutations.

    David R Bangsberg;Edwin D Charlebois;Robert M Grant;Mark Holodniy

  • Early and extended early bactericidal activity of levofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis

    John L. Johnson;D. J. Hadad;W. H. Boom;C. L. Daley

  • Population-Based Community Prevalence of Methicillin-Resistant Staphylococcus aureus in the Urban Poor of San Francisco

    Edwin D. Charlebois;David R. Bangsberg;Nicholas J. Moss;Matthew R. Moore

  • Community-Adapted Methicillin-Resistant Staphylococcus aureus (MRSA): Population Dynamics of an Expanding Community Reservoir of MRSA

    Heather A Carleton;Binh An Diep;Edwin D. Charlebois;George F. Sensabaugh

  • Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals

    Annie F. Luetkemeyer;Edwin D. Charlebois;Laura L. Flores;David R. Bangsberg

  • Provider assessment of adherence to HIV antiretroviral therapy.

    David R. Bangsberg;Frederick M. Hecht;Heather Clague;Edwin D. Charlebois

  • Dihydroartemisinin–Piperaquine for the Prevention of Malaria in Pregnancy

    Abel Kakuru;Prasanna Jagannathan;Mary K. Muhindo;Paul Natureeba

  • Increasing Prevalence of Methicillin-Resistant Staphylococcus aureus Infection in California Jails

    Erica S. Pan;Binh A. Diep;Heather A. Carleton;Edwin D. Charlebois

  • HIV Seroprevalence Among Homeless and Marginally Housed Adults in San Francisco

    Marjorie J. Robertson;Richard A. Clark;Edwin D. Charlebois;Jacqueline Tulsky

  • Theory-Guided, Empirically Supported Avenues for Intervention on HIV Medication Nonadherence: Findings from the Healthy Living Project

    Mallory O. Johnson;Sheryl L. Catz;Robert H. Remien;Mary Jane Rotheram-Borus

  • Positive provider interactions, adherence self-efficacy, and adherence to antiretroviral medications among HIV-infected adults: A mediation model.

    Mallory O. Johnson;Margaret A. Chesney;Rise B. Goldstein;Robert H. Remien

  • HIV Testing and Treatment with the Use of a Community Health Approach in Rural Africa

    Diane V Havlir;Laura B Balzer;Edwin D Charlebois;Tamara D Clark

  • Origins of Community Strains of Methicillin-Resistant Staphylococcus aureus

    Edwin D. Charlebois;Françoise Perdreau-Remington;Barry Kreiswirth;David R. Bangsberg

  • Removing barriers to knowing HIV status: same-day mobile HIV testing in Zimbabwe.

    Stephen F Morin;Gertrude Khumalo-Sakutukwa;Edwin D Charlebois;Janell Routh

  • Comparing Objective Measures of Adherence to HIV Antiretroviral Therapy: Electronic Medication Monitors and Unannounced Pill Counts

    David R. Bangsberg;Frederick M. Hecht;Edwin D. Charlebois;Margaret Chesney

Frequent Co-Authors

Diane V. Havlir
Diane V. Havlir University of California, San Francisco
Moses R. Kamya
Moses R. Kamya Makerere University
Elizabeth A. Bukusi
Elizabeth A. Bukusi University of Washington
Grant Dorsey
Grant Dorsey University of California, San Francisco
David R. Bangsberg
David R. Bangsberg Simon Fraser University
Stephen F. Morin
Stephen F. Morin University of California, San Francisco
Philip J. Rosenthal
Philip J. Rosenthal University of California, San Francisco
Harsha Thirumurthy
Harsha Thirumurthy University of Pennsylvania
Robert H. Remien
Robert H. Remien Columbia University
Margaret A. Chesney
Margaret A. Chesney University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those studying Immunology in the USA, exploring related healthcare degrees can open diverse career opportunities. Many students consider advancing their qualifications through specialized nursing programs that complement immunology knowledge. For instance, enrolling in a nurse practitioner accelerated program offers a streamlined pathway to becoming an advanced practice nurse while applying immunological principles in patient care.

Students without prior nursing experience may find online BSN programs for non nurses particularly advantageous. These programs provide the flexibility and foundational knowledge necessary to enter the nursing field and build expertise related to immunology.

For quicker access to the nursing profession, options like the easiest accelerated nursing programs and fastest and easiest LPN programs offer practical routes. These pathways allow candidates to gain licensure and begin working in healthcare settings where immunological expertise is highly valuable.

By combining immunology studies with these related online degrees, students can enhance their skill sets and improve career prospects in nursing, healthcare research, and clinical roles focusing on immune system health and disease management.

Best Scientists Citing Edwin D. Charlebois

Trending Scientists

Recently Published Articles